Home » Archive

Marketwire, News, Syndication »

Medistem Appoints Director of Chinese Operations

Posted by Mary Canady March 29th, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – Mar 29, 2012) – Medistem Inc. (PINKSHEETS: MEDS) announced today the appointment of Feng Lin, MD, Ph.D as Director of Chinese Operations. Dr. Lin has an extensive background in basic research and therapeutics development…

More...

Marketwire, News, Syndication »

Mentor Capital to Discuss Major Cancer Funding, Low PE and Warrant Call at April 29 Shareholder Meeting

Posted by Mary Canady March 28th, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – Mar 28, 2012) – Mentor Capital, Inc. (PINKSHEETS: MNTR) will hold its annual shareholders’ meeting at the company offices outside of San Diego, April 29, 2012 at 10:00AM. A management report and director ballots are being…

More...

Marketwire, News, Syndication »

Quidel Receives CE Mark for Its AmpliVue(TM) Hand-Held Molecular Diagnostic Test for Clostridium Difficile

Posted by Mary Canady March 27th, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – Mar 27, 2012) – Quidel Corporation (NASDAQ: QDEL), announced today that it received CE mark for the AmpliVue C. difficile assay, its non-instrumented molecular test for the detection of toxigenic Clostridium difficile ba…

More...

Marketwire, News, Syndication »

Senomyx to Webcast Corporate Presentation at the 11th Annual Needham Healthcare Conference

Posted by Mary Canady March 27th, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – Mar 27, 2012) – Senomyx, Inc. (NASDAQ: SNMX), a company using proprietary taste science technologies to discover and develop novel flavor ingredients for the food, beverage, and ingredient supply industries, announced to…

More...

Marketwire, News, Syndication »

Quidel Receives FDA Clearance for Its Quidel Molecular(TM) Influenza A+B Assay for Use With Cepheid SmartCycler(R)

Posted by Mary Canady March 22nd, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – Mar 22, 2012) – Quidel Corporation (NASDAQ: QDEL), a leading provider of diagnostic testing solutions, announced today that it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for i…

More...

Marketwire, News, Syndication »

Entest BioMedical Excited With Progress on 10 Dog Pilot Study of "Universal Donor" Stem Cell Treatment for Canine Osteoarthritis

Posted by Mary Canady March 21st, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – Mar 21, 2012) – Entest BioMedical Inc. (OTCQB: ENTB) (PINKSHEETS: ENTB)

Entest’s McDonald Animal Hospital has treated 8 dogs in 10 Dog Pilot Study.

All of which are showing pos…

More...

Marketwire, News, Syndication »

Medistem Shareholder Update: March 2012

Posted by Mary Canady March 20th, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – Mar 20, 2012) – Medistem Inc. (PINKSHEETS: MEDS) today issues the following letter to shareholders.
Dear Fellow Shareholder:
Since our last update in December 2011, we would like to comment on several impo…

More...

Marketwire, News, Syndication »

Cytori Breast Reconstruction Cell Therapy Trial Results Published

Posted by Mary Canady March 19th, 2012 .
No Comments

ZUG, SWITZERLAND and SAN DIEGO, CA–(Marketwire – Mar 19, 2012) – Cytori Therapeutics (NASDAQ: CYTX) announced today the publication of RESTORE-2 trial results in the peer-reviewed European Journal of Surgical Oncology.
RESTORE-2 is a 71 pat…

More...

Marketwire, News, Syndication »

Cytori Breast Reconstruction Cell Therapy Trial Results Published

Posted by Mary Canady March 19th, 2012 .
No Comments

ZUG, SWITZERLAND and SAN DIEGO, CA–(Marketwire – Mar 19, 2012) – Cytori Therapeutics (NASDAQ: CYTX) announced today the publication of RESTORE-2 trial results in the peer-reviewed European Journal of Surgical Oncology.
RESTORE-2 is a 71 pat…

More...

Marketwire, News, Syndication »

FDA Grants Cytori 510(k) Clearance for Puregraft(R) 850

Posted by Mary Canady March 16th, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – Mar 16, 2012) – Cytori (NASDAQ: CYTX) has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Puregraft® 850 System for body contouring using a patient’s own fat. The Puregraft® 850 produ…

More...